[HTML][HTML] The regulatory role of microRNAs in breast cancer

HY Loh, BP Norman, KS Lai, NMANA Rahman… - International journal of …, 2019 - mdpi.com
MicroRNAs (miRNAs) are small non-coding RNA molecules which function as critical post-transcriptional
gene regulators of various biological functions. Generally, miRNAs negatively …

Efficacy and safety of once-daily nitisinone for patients with alkaptonuria (SONIA 2): an international, multicentre, open-label, randomised controlled trial

…, A Mistry, V Mlynarikova, BP Norman… - The Lancet Diabetes & …, 2020 - thelancet.com
Background Alkaptonuria is a rare, genetic, multisystem disease characterised by the
accumulation of homogentisic acid (HGA). No HGA-lowering therapy has been approved to date. …

Ochronotic pigmentation is caused by homogentisic acid and is the key event in alkaptonuria leading to the destructive consequences of the disease—a review

LR Ranganath, BP Norman… - Journal of inherited …, 2019 - Wiley Online Library
Ochronosis is the process in alkaptonuria (AKU) that causes all the debilitating morbidity.
The process involves selective deposition of homogentisic acid (HGA)‐derived pigment in …

[HTML][HTML] Post-transcriptional regulatory crosstalk between MicroRNAs and canonical TGF-β/BMP signalling cascades on osteoblast lineage: a comprehensive review

HY Loh, BP Norman, KS Lai, WH Cheng… - International journal of …, 2023 - mdpi.com
MicroRNAs (miRNAs) are a family of small, single-stranded, and non-protein coding RNAs
about 19 to 22 nucleotides in length, that have been reported to have important roles in the …

Pigmentation chemistry and radical‐based collagen degradation in alkaptonuria and osteoarthritic cartilage

WY Chow, BP Norman, NB Roberts… - Angewandte Chemie …, 2020 - Wiley Online Library
Alkaptonuria (AKU) is a rare disease characterized by high levels of homogentisic acid (HGA);
patients suffer from tissue ochronosis: dark brown pigmentation, especially of joint …

Nitisinone causes acquired tyrosinosis in alkaptonuria

…, AM Milan, AS Davison, BP Norman… - Journal of Inherited …, 2020 - Wiley Online Library
For over two decades, nitisinone (NTBC) has been successfully used to manipulate the
tyrosine degradation pathway and save the lives of many children with hereditary tyrosinaemia …

Homogentisic acid is not only eliminated by glomerular filtration and tubular secretion but also produced in the kidney in alkaptonuria

…, AS Davison, E Shweihdi, BP Norman… - Journal of Inherited …, 2020 - Wiley Online Library
The clinical effects of alkaptonuria (AKU) are delayed and ageing influences disease
progression. Morbidity of AKU is secondary to high circulating homogentisic acid (HGA) and …

Comparing nitisinone 2 mg and 10 mg in the treatment of alkaptonuria—an approach using statistical modelling

…, AM Milan, AT Hughes, M Khedr, BP Norman… - JIMD …, 2022 - Wiley Online Library
… Milan, Andrew T Hughes, and Brendan P. Norman carried out the metabolic analyses,
drafting manuscript, and final approval of the manuscript. Milad Khedr and Mohammed Alsbou …

[HTML][HTML] Metabolomic studies in the inborn error of metabolism alkaptonuria reveal new biotransformations in tyrosine metabolism

BP Norman, AS Davison, JH Hughes, H Sutherland… - Genes & …, 2022 - Elsevier
Alkaptonuria (AKU) is an inherited disorder of tyrosine metabolism caused by lack of active
enzyme homogentisate 1,2-dioxygenase (HGD). The primary consequence of HGD …

Temporal adaptations in the phenylalanine/tyrosine pathway and related factors during nitisinone-induced tyrosinaemia in alkaptonuria

…, B Olsson, M Rudebeck, R Imrich, BP Norman… - Molecular genetics and …, 2022 - Elsevier
… Mean sPHE, TBWPHE and cPHE24 where all higher at V2 than at V1, ie, after introduction
of NIT, and showed a consistent further increase at the following visits (p < 0.01, V6 vs V1), …